WAI CHUN BIOTEC(00660): Possible delay in publishing full-year performance.
Weijun Biotechnology (00660) issued an announcement that the company's Chief Financial Officer will be on leave from September 14, 2024 due to family reasons.
WAI CHUN BIOTEC (00660) announces that the company's Chief Financial Officer has resigned from September 14, 2024 due to personal reasons, causing hindrances in providing information and documents to the auditors. As a result, the company needs additional time to finalize the audited financial results for the year ending June 30, 2024, and it may be delayed beyond the original announcement date of September 30, 2024.
The company is working closely with the auditors to provide all required information and documents to expedite the auditing process. However, the expected announcement date for the annual results will need to be further determined with the auditors and will be announced separately.
Related Articles

US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.

US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%

US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.
US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.

US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%

US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.

RECOMMEND

Rare Sales Decline for Tank Brand—How Will Great Wall Motor Defend Its Market Position?
14/07/2025

Inside the Explosive Growth of the New Tea Beverage Sector: Supply Chains, Innovation, and Cultural Capital
14/07/2025

Hafu Securities Joins the Race as Hong Kong Accelerates Its Push to Become a Virtual Asset Hub
14/07/2025